The international research summit on cerebral venous thrombosis is a small-scale research meeting. Cerebral venous thrombosis (CVT) is a rare type of stroke. CVT is caused by a blockage of a vein (a sinus) in the brain. Veins are blood vessels that drain oxygen-poor blood from the organs to the heart and lungs. Because of the blockage of the vein in the brain, the drainage of blood is disturbed. CVT mostly affects patients aged 20 to 50 years. A severe headache is the most common – and usually first – complaint. In addition, CVT can also cause loss of bodily functions (such as paralysis of an arm and/or leg or speech difficulties) and epileptic seizures.
Further research is necessary to better diagnose and treat patients with CVT. During the two-day international research summit on cerebral venous thrombosis 2023, a group of around 40 experts in the field, together with patients and funding organizations, will discuss where research on CVT should focus on in the coming decade. This will lead to a research agenda that will unite those involved in CVT research from all over the world.
The research summit will take place in Amsterdam (The Netherlands) on June 1-2, 2023 and will consist of multiple sessions in which different themes, such as diagnostic tests or treatment, will be addressed. These sessions will lead to concrete research plans, which then form the research agenda. We also aim to include patients with CVT and media to strengthen the public support of the research agenda.
Conference Website: https://cerebralvenousthrombosis.com/cvt-summit-2023/
